Environment’s impact on health
What is the Environment’s impact on health at AstraZeneca?
Company efforts to prevent disease and improve health outcomes by addressing environmental determinants of health. These determinants include climate change, air and water quality, the built environment, and the environmental dimension of antimicrobial resistance (AMR).
Our approach recognises that the health of our planet and the health of people are intrinsically linked. We address our environmental impacts from the beginning of our research process all the way through to cross-sector collaborations for improved health of people and the planet.
We know that the benefits from reducing our environmental footprint can take effect within a few years of reducing emissions and modifying environments. This can in turn help prevent certain diseases,1 such as chronic obstructive pulmonary disease, lung cancers, stroke and heart disease.
In 2020, we committed to health equity — to ensuring that everyone has an equal opportunity to be as healthy as possible, by removing barriers to access and eliminating discrimination from the delivery of healthcare. This compels us to consider health disparities faced by populations disproportionately affected by pollution and unhealthy environments.
- Increasing our understanding of environment’s impact on health in relation to our therapy areas
- Driving improved environmental performance of our operations for measured impact on human health
- Life cycle considerations of human health impacts for manufacture, use and disposal of our products
- New programmes and scaling existing programmes to improve human health through a healthier environment
- Cross-sector collaborations and research for environmental health indicators and outcomes